Derivation of clinical-grade induced pluripotent stem cell lines from erythroid progenitor cells in xenofree conditions

G Singh, KV Manian, C Premkumar… - … Pluripotent Stem (iPS) …, 2021 - Springer
One of the major hurdles in realizing the therapeutic potential of human-induced pluripotent
stem cells (iPSC) is the generation of clinical-grade iPSC lines and their differentiated …
被引用次数：3 相关文章

Derivation of Clinical-Grade Induced Pluripotent Stem Cell Lines from Erythroid Progenitor Cells in Xenofree Conditions

G Singh, KV Manian, C Premkumar… - … Pluripotent Stem (iPS) …, 2022 - Springer
One of the major hurdles in realizing the therapeutic potential of human-induced pluripotent
stem cells (iPSC) is the generation of clinical-grade iPSC lines and their differentiated …

Derivation of Clinical-Grade Induced Pluripotent Stem Cell Lines from Erythroid Progenitor Cells in Xenofree Conditions.

G Singh, KV Manian, C Premkumar… - Methods in Molecular …, 2022 - europepmc.org
One of the major hurdles in realizing the therapeutic potential of human-induced pluripotent
stem cells (iPSC) is the generation of clinical-grade iPSC lines and their differentiated …

Derivation of Clinical-Grade Induced Pluripotent Stem Cell Lines from Erythroid Progenitor Cells in Xenofree Conditions

G Singh, KV Manian, C Premkumar… - … biology (Clifton, NJ …, 2022 - pubmed.ncbi.nlm.nih.gov
One of the major hurdles in realizing the therapeutic potential of human-induced pluripotent
stem cells (iPSC) is the generation of clinical-grade iPSC lines and their differentiated …